Tag: MASH
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Semaglutide Approved for Advanced Liver Disease: First GLP-1 Drug to Treat MASH with Fibrosis
Semaglutide (Wegovy) has become the first glucagon-like peptide-1 receptor agonist approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver…
Experimental drug ION224 shows promise against severe fatty liver disease in UC San Diego trials
UC San Diego researchers have developed ION224, an experimental drug that targets liver enzymes to treat MASH, a severe fatty…
Submit Your Paper to GMJ
No APC until January 2027.